PFAPA Syndrome — the acronym designating Periodic Fever, Aphthous stomatitis, Pharyngitis, and Adenitis, representing the most prevalent autoinflammatory periodic fever syndrome of childhood and the most common cause of recurrent febrile episodes in young children in developed countries, described originally by Marshall et al. in 1987 and now recognized as a distinct clinical entity characterized by its unparalleled periodicity where fever episodes recur with clockwork regularity at intervals of 3–8 weeks throughout a child's early years, each episode beginning abruptly with fever rising to 38.5–40.5°C and lasting 3–6 days before resolving completely and spontaneously regardless of treatment, accompanied in varying combinations by aphthous oral ulcers (painful shallow erosions of the buccal mucosa, lateral tongue, and labial mucosa, typically 2–5 lesions per episode), exudative or non-exudative pharyngitis with pharyngeal erythema, and cervical lymphadenopathy (typically 1–3 enlarged cervical nodes bilaterally or unilaterally during episodes), with the child returning entirely to normal health and normal growth trajectory in the afebrile interictal periods that distinguish PFAPA from the continuous inflammatory activity of systemic autoinflammatory diseases; affecting children primarily between ages 2 and 5 years at onset (though cases with onset up to age 12 are recognized), with an estimated prevalence of 2–4 per 10,000 children in population-based studies and a higher prevalence in clinical series from tertiary pediatric immunology centers, without definitive genetic cause identified in the majority of cases despite association with IL-1β, IL-18, and inflammasome-related pathway polymorphisms in a subset of patients; diagnosed entirely on clinical grounds by the modified Marshall criteria requiring periodic febrile episodes recurring at predictable intervals of 3–6 weeks (intervals between 2 and 8 weeks are accepted), accompanied by at least one of aphthous stomatitis, pharyngitis, or cervical adenitis, with normal physical examination between episodes, normal growth and development, and appropriate exclusion of cyclic neutropenia (by CBC during and between fever episodes to confirm normal absolute neutrophil count during episodes), familial Mediterranean fever (by MEFV genotype testing), hyper-IgD syndrome (by MVKK genetic testing and urine mevalonic acid), TRAPS (TNFRSF1A genotype), and CAPS (NLRP3 genotype) in patients with atypical features or family history suggesting hereditary autoinflammatory syndromes; managed acutely with a single oral dose of corticosteroid (prednisone or prednisolone 1–2 mg/kg, maximum 60 mg) or betamethasone at episode onset, which aborts the fever episode within hours in 75–95% of PFAPA cases but may paradoxically shorten the interepisode interval in some patients by removing the episode-terminating immunological signal; and treated definitively in the majority of cases with tonsillectomy (with or without adenoidectomy), which achieves complete or near-complete resolution of periodic fever episodes in 50–100% of children across multiple randomized and observational studies and represents the most cost-effective long-term therapeutic option for children with frequent episodes disrupting school attendance, family schedules, and quality of life, with medical alternative management using monthly colchicine prophylaxis or cimetidine showing modest efficacy in select patients who defer or decline surgical intervention.
PFAPA Syndrome technology platforms — whether supporting pediatric infectious disease, immunology, and general pediatrics programs coordinating systematic episode documentation platforms recording fever onset time, peak temperature, episode duration, aphthous ulcer count and location, pharyngitis grading, cervical adenopathy documentation, and complete resolution date for each episode in the patient's longitudinal fever log, periodicity calculation platforms computing interepisode interval statistics from the fever diary to confirm the characteristic 3–8 week regularity that distinguishes PFAPA from infection-driven recurrent fever, trigger pattern analysis platforms identifying potential episode triggers including stress, viral upper respiratory infections, and seasonal variation that modulate PFAPA episode timing without abolishing its fundamental periodicity, corticosteroid response tracking platforms documenting the hours-to-fever-resolution and whether steroid administration shortened the episode as expected for diagnostic confirmation, genetic testing coordination platforms managing MEFV, MVK, TNFRSF1A, NLRP3, and LPIN2 genotype result documentation and variant classification for exclusion of hereditary autoinflammatory fever syndromes, cyclic neutropenia CBC surveillance platforms coordinating blood counts during and between episodes to confirm preserved neutrophil counts during PFAPA fever (which distinguishes PFAPA from cyclic neutropenia where fever correlates with the neutrophil nadir), tonsillectomy surgical coordination platforms managing ENT surgical scheduling, perioperative corticosteroid management, and post-tonsillectomy fever diary follow-up confirming resolution, growth and development monitoring platforms tracking height and weight velocity to confirm the normal growth trajectory that characterizes PFAPA despite frequent fever episodes (and deviations that prompt reconsideration of the diagnosis), laboratory coordination platforms managing IL-18, serum amyloid A, CRP, ESR, and CBC trending during episodes and between episodes to document the inflammatory signature and its complete normalization in interictal periods, and family education and fever diary platforms enabling families to log episodes remotely with automatic interval calculation and episode pattern visualization — must maintain the availability and performance that PFAPA's diagnostic precision requirements, episode documentation regularity, corticosteroid response tracking, and surgical coordination impose. This guide explains why PFAPA tech platforms need dedicated monitoring, what to monitor, and how to build a monitoring strategy matching the complexity of modern PFAPA syndrome care.
Why PFAPA Syndrome Tech Platforms Require Specialized Monitoring Attention
PFAPA management is defined by the diagnostic precision challenge where the confidence of the PFAPA diagnosis rests entirely on clinical documentation — the measured periodicity, the consistent symptom complex, the complete interictal normality, and the corticosteroid responsiveness — such that fever diary platforms generating the longitudinal episode record are the primary diagnostic instrument and their availability during fever episodes is the point where PFAPA clinical documentation either succeeds or fails, the tonsillectomy decision support imperative where accumulated fever diary data quantifying episode frequency, school day impact, family disruption, and corticosteroid interval-shortening effect drives the surgical intervention decision, the differential diagnosis exclusion obligation requiring scheduled genetic testing and cyclic neutropenia CBC coordination to safely maintain the PFAPA diagnosis as the child's fever pattern evolves, the corticosteroid interval-shortening surveillance requirement identifying the subgroup of PFAPA patients whose prednisone response shortens interepisode intervals (in whom corticosteroid abort therapy should be abandoned in favor of colchicine prophylaxis or direct surgical referral), and the post-tonsillectomy follow-up documentation obligation confirming episode resolution that validates the surgical intervention and permits discharge from periodic fever surveillance. Technology failures in these domains create disruptions calibrated to the documentation-dependent diagnosis and the scheduling-dependent tonsillectomy referral pathway of PFAPA.
Fever diary and episode documentation platforms are the primary diagnostic instruments. PFAPA is a clinical diagnosis where the fever log — recording the date, duration, temperature peak, and symptom complex of each episode over six to twelve consecutive cycles — is the single most important diagnostic document; platform failures during active fever episodes when families are attempting to log the current episode's onset, temperature, aphthous ulcer presence, and pharyngitis grade interrupt the systematic documentation that confirms periodicity and drives diagnostic confidence and tonsillectomy referral decisions. Monitor fever diary platforms at 1-minute intervals during business and evening hours.
Periodicity analysis platforms identify the defining PFAPA rhythm. Automatic calculation of interepisode interval statistics — mean interval, interval range, interval coefficient of variation — transforms raw fever diary data into the periodicity evidence that distinguishes PFAPA's clockwork recurrence from infection-driven fever where intervals lack the precision-regularity characteristic; platform failures interrupt the analytical output that communicates diagnostic confidence to families and consulting ENT surgeons. Monitor periodicity analysis platforms during clinical hours.
Tonsillectomy coordination platforms enable the definitive intervention. ENT surgical referral scheduling, pre-surgical fever diary documentation package assembly, perioperative corticosteroid management coordination, and post-tonsillectomy fever diary follow-up confirming episode resolution — the complete surgical pathway for a PFAPA patient whose episode frequency, school impact, and corticosteroid interval-shortening effect meet the tonsillectomy threshold — requires continuous platform availability from referral through post-surgical confirmation. Monitor tonsillectomy coordination platforms during business hours.
Cyclic neutropenia exclusion CBC platforms protect diagnostic safety. CBC documentation confirming normal absolute neutrophil count during PFAPA fever episodes — performed during the first one to three fever episodes in the diagnostic evaluation to exclude cyclic neutropenia where fever correlates with the neutrophil nadir and where the management is G-CSF not tonsillectomy — requires laboratory platform availability during the fever episode presentation window. Monitor CBC and laboratory platforms at 1-minute intervals during clinical hours.
What to Monitor on a Pediatric Systemic Autoinflammatory Disease Tech Platform
Fever Diary and Episode Documentation
Monitor fever episode logging records with onset date and time, peak temperature, episode duration in days, complete resolution date, aphthous ulcer count and anatomical distribution records, pharyngitis severity grading records (erythema only, exudate, soft palate involvement), cervical lymphadenopathy documentation records with node size and laterality, and family-submitted remote fever diary entries via patient portal or mobile diary application at 1-minute intervals during business and evening hours (fever episodes occur around the clock and the family must be able to log episode onset at any time). Alert on sustained failures — fever diary platform failures during active fever episode onset prevent the real-time episode documentation that captures the precise onset timing, symptom complex, and temperature trajectory that defines the PFAPA episode record; a missed episode entry interrupts the continuous fever log on which the periodicity calculation and tonsillectomy decision support depend.
Periodicity Calculation and Pattern Analysis
Monitor automatic interepisode interval calculation records (computing intervals between each consecutive episode pair in the fever log with mean, median, range, and coefficient of variation output), periodicity visualization records displaying the fever episode timeline with interval annotations, corticosteroid response documentation records tracking hours-from-prednisone-to-fever-resolution for each episode where abort therapy was used, interval-shortening detection records identifying patients whose post-corticosteroid interepisode interval is shorter than their pre-corticosteroid baseline interval (the interval-shortening adverse effect that changes management), trigger pattern annotation records allowing families to document concurrent URI, stress, or other potential modulating events, and clinical summary report generation records assembling the fever diary, periodicity statistics, and corticosteroid response data into the tonsillectomy referral package at 1-minute intervals during clinical hours. Alert on sustained failures — periodicity calculation platform failures interrupt the statistical analysis that transforms raw fever diary entries into the quantitative evidence of interval regularity that confirms the PFAPA diagnosis and communicates it to consulting ENT surgeons who require interval statistics before scheduling tonsillectomy.
Corticosteroid Management and Response Tracking
Monitor prednisone or prednisolone prescribing records for abort therapy (single dose 1–2 mg/kg, maximum 60 mg at episode onset), corticosteroid response documentation records confirming fever resolution within 4–12 hours (confirming abort therapy efficacy), episode recurrence timing records after corticosteroid administration (identifying interval shortening), betamethasone prescribing records as an alternative abort agent, colchicine prophylaxis prescribing records (0.5–1 mg/day in children unable to have tonsillectomy or in whom abort therapy causes interval shortening), cimetidine H2-blocker prescribing records for families declining corticosteroid abort therapy, and steroid adverse effect documentation records including appetite increase, behavior change, and sleep disruption after repeated corticosteroid abort courses during business hours. Alert on sustained failures — corticosteroid prescribing platform failures during an active fever episode when the family contacts the clinic for the abort dose interrupts the prednisone prescribing workflow that would resolve the current episode within hours and allow the child to return to normal function the following day.
Differential Diagnosis Exclusion and Genetic Testing
Monitor MEFV gene mutation analysis records for familial Mediterranean fever exclusion (particularly in children with any Mediterranean ancestry, serositis, or amyloidosis risk features), MVK (mevalonate kinase) genetic testing records for hyper-IgD syndrome exclusion (particularly in children with lymphadenopathy-predominant episodes or elevated IgD), TNFRSF1A mutation records for TRAPS exclusion (particularly in children with prolonged episodes exceeding 7 days, periorbital edema, migratory myalgia, or family history), NLRP3 mutation records for CAPS exclusion (particularly in children with urticaria, cold sensitivity, or sensorineural hearing loss), cyclic neutropenia CBC records confirming normal ANC during fever episodes (obtained at the first one to three fever episodes), periodic CBC records between episodes confirming that neutrophil counts do not cycle into neutropenic range, serum IL-18 records (markedly elevated in NLRP3-related and other inflammasome-driven disorders where elevation may influence diagnosis), and variant of uncertain significance (VUS) genetic counseling records when autoinflammatory genetic panels return inconclusive results during business hours. Alert on sustained failures — differential diagnosis exclusion platform failures delay the cyclic neutropenia CBC during an active fever episode, risking the failure to identify the ANC nadir that would change the diagnosis from PFAPA to cyclic neutropenia and redirect management from corticosteroid abort therapy to G-CSF.
Tonsillectomy Coordination and Post-Surgical Follow-Up
Monitor ENT surgical referral scheduling records with fever diary documentation package transmission, pre-surgical evaluation records including tonsil size grading and adenoid hypertrophy assessment, tonsillectomy (with or without adenoidectomy) surgical scheduling and procedure records, perioperative fever management records (febrile episodes may occur in the early post-tonsillectomy recovery period before the surgical benefit is established), post-tonsillectomy fever diary follow-up records at one, three, six, and twelve months confirming episode resolution or frequency reduction, post-tonsillectomy relapse documentation records for children who experience recurrent episodes after tonsillectomy (approximately 10–15% of patients), fever diary continuation records in partial responders documenting residual episode frequency for secondary medical management decisions, and PFAPA remission documentation records for patients achieving complete spontaneous resolution (which occurs in most children by mid-adolescence regardless of tonsillectomy status) during business hours. Alert on sustained failures — tonsillectomy coordination platform failures interrupt the ENT referral scheduling workflow for a child with frequent PFAPA episodes causing multiple school absences monthly and documented corticosteroid interval-shortening effect where the accumulation of tonsillectomy referral package data and surgical scheduling represents the definitive treatment pathway.
Growth, Development, and Quality of Life Monitoring
Monitor height and weight velocity records at each visit (PFAPA does not impair growth, and growth deceleration prompts reassessment of the diagnosis), school attendance impact records documenting number of school days missed per fever episode and per year (the primary quality-of-life driver motivating tonsillectomy in otherwise clinically stable PFAPA), validated quality-of-life instrument records (PedsQL or equivalent) at baseline and post-tonsillectomy follow-up, family burden documentation records tracking parental work disruption from fever episode management, neurodevelopmental assessment records if episode frequency or treatment affects school performance, and spontaneous remission monitoring records for adolescent PFAPA patients where the natural history of resolution by mid-adolescence may preempt the surgical decision during business hours. Alert on sustained failures — growth monitoring platform failures interrupt the height velocity comparison that distinguishes the normal growth trajectory of PFAPA from the growth deceleration that raises the possibility of an underlying systemic autoinflammatory disease, chronic infection, or inflammatory bowel disease that had been misclassified as PFAPA.
Authentication and Clinical Identity
Monitor authentication at 1-minute intervals, 24/7. PFAPA programs coordinate across pediatric infectious disease, immunology, general pediatrics, ENT surgery, family medicine, school nursing services, and patient portals where the family must log fever episodes remotely — authentication failures block the remote episode documentation workflow that is the primary data collection mechanism for the fever diary.
SSL Certificates
Monitor SSL certificate expiry across all patient portals, fever diary applications, periodicity analysis platforms, tonsillectomy coordination systems, and genetic testing result platforms. Certificate errors disrupt the episode documentation, analytical, and surgical coordination workflows that PFAPA management depends upon.
HIPAA and Pediatric Autoinflammatory Disease Data Privacy Considerations
PFAPA Syndrome technology platforms handle sensitive pediatric PHI including fever diary records documenting multiple years of recurrent illness episodes in a minor with implications for insurance eligibility and disability assessment, genetic testing records from hereditary autoinflammatory fever syndrome exclusion panels where MEFV and MVK variant results may reveal carrier status for familial Mediterranean fever or hyper-IgD syndrome with implications for the patient's siblings and parents and future family planning, tonsillectomy surgical records documenting the operative intervention and its outcome in a minor's permanent surgical history, corticosteroid exposure documentation where repeated abort therapy courses create a documented steroid exposure record, and quality-of-life and school attendance records quantifying the educational impact of PFAPA that may be relevant to special education accommodation requests. HIPAA Security Rule requirements for PHI availability and integrity apply across all platform components managing this PHI.
For platforms managing autoinflammatory genetic panel results in pediatric PFAPA patients — where MEFV carrier status identified during TRAPS/FMF exclusion testing reveals heterozygous pathogenic variants with implications for sibling carrier risk and for the patient's risk of FMF or inflammatory bowel disease associated with MEFV heterozygosity — the return of genetic results to pediatric patients and their families requires the privacy and access controls that incidental genetic findings in minors demand under HIPAA and applicable state genetic privacy statutes.
Alerting Strategy for PFAPA Syndrome Tech Platforms
Immediate 24/7 alerting: Authentication systems; fever diary episode logging platforms (families log onset at any hour).
Immediate business-hours alert: Cyclic neutropenia exclusion CBC platforms during active fever episodes; corticosteroid prescribing platforms when families contact for abort dose.
Sustained-failure alert (10–15 minutes): Periodicity calculation and pattern analysis platforms; tonsillectomy coordination scheduling platforms; genetic testing result platforms; growth and development monitoring platforms.
30-day advance warning: SSL certificates across all domains.
Vigilmon's multi-region monitoring confirms PFAPA platform availability from the geographies where comprehensive pediatric autoinflammatory disease programs with dedicated periodic fever syndrome expertise, genetic testing coordination, and tonsillectomy referral pathways concentrate — important for a condition where the documentation-dependent diagnosis and the scheduling-dependent definitive treatment together depend entirely on platform availability during the 3–8 week cycle of recurring fever episodes.
Status Page for PFAPA Syndrome Care Team Communication
A real-time status page gives pediatric immunologists reviewing fever diary periodicity data, ENT surgeons evaluating tonsillectomy referral packages, genetic counselors reviewing autoinflammatory panel results, general pediatricians prescribing abort therapy, and families logging active fever episodes immediate platform visibility without requiring inbound IT support contact. During a fever diary platform outage at the onset of a child's eighteenth consecutive PFAPA episode when the family is attempting to log the episode and the care team is reviewing the periodicity record to complete the tonsillectomy referral, a status page enables immediate contingency protocol activation.
Include the status page URL in PFAPA program fever diary fallback procedures, tonsillectomy referral emergency protocols, corticosteroid abort therapy prescribing downtime workflows, and cyclic neutropenia exclusion CBC clinical contingency plans.
Vigilmon Setup for PFAPA Syndrome Tech Platforms
A practical starting configuration:
| Monitor | Check Interval | Alert Channel | |---------|----------------|---------------| | Authentication | 1 min | Slack + PagerDuty (24/7) | | Fever diary / episode logging platform | 1 min | Slack + PagerDuty (24/7) | | Corticosteroid prescribing / abort therapy | 1 min | Slack + PagerDuty (clinical hours) | | Cyclic neutropenia exclusion CBC platforms | 1 min | Slack + PagerDuty (clinical hours) | | Periodicity calculation / pattern analysis | 2 min | Slack (business hours) | | Tonsillectomy coordination / ENT referral | 2 min | Slack (business hours) | | Genetic testing coordination / result platforms | 2 min | Slack (business hours) | | Growth and development monitoring | 2 min | Slack (business hours) | | Post-tonsillectomy follow-up diary | 2 min | Slack (business hours) | | Quality-of-life / school attendance tracking | 2 min | Slack (business hours) | | Patient portal / family fever diary | 1 min | Slack + PagerDuty (24/7 — families log at any hour) | | SSL: all domains | Daily | Email (30-day warning) |
Getting started:
- Create a free account at vigilmon.online
- Add authentication endpoints at 1-minute intervals with 24/7 alerting
- Configure fever diary and episode logging platforms with 24/7 alerting — fever episodes occur at any hour and families must log onset immediately
- Add corticosteroid abort therapy prescribing platforms with immediate clinical-hours alerting
- Configure cyclic neutropenia exclusion CBC platforms with immediate clinical-hours alerting during fever episodes
- Add periodicity calculation and pattern analysis platforms with sustained-failure alerting
- Configure tonsillectomy coordination and ENT referral platforms with sustained-failure alerting
- Add genetic testing coordination and result documentation platforms with sustained-failure alerting
- Configure growth monitoring and height velocity tracking with sustained-failure alerting
- Add post-tonsillectomy follow-up fever diary platforms with sustained-failure alerting
- Configure quality-of-life and school attendance tracking with sustained-failure alerting
- Enable SSL certificate monitoring across all clinical, family-facing, and surgical coordination domains
- Add the status page URL to PFAPA fever diary fallback procedures, corticosteroid abort therapy downtime workflows, and tonsillectomy referral contingency plans
Conclusion
PFAPA Syndrome technology platforms are embedded in clinical decisions where fever diary platform availability at 2:00 AM when a four-year-old's parents recognize the unmistakable onset of his twenty-first PFAPA episode — the fever that began at 38.7°C after his normal bedtime, accompanied by the two aphthous ulcers on his left buccal mucosa that have appeared in precisely this location during every episode since his first at age two and a half, now recurring three weeks and four days after his twentieth episode resolved, confirming the 23-day interepisode interval that his fever log has documented across the past sixteen months — must allow the family to log the episode immediately with onset time, initial temperature, and ulcer count so that the episode is captured in the longitudinal fever diary that the care team will assemble into the tonsillectomy referral package when the cumulative burden of twenty-one episodes across two years of preschool and early kindergarten, representing forty-two weeks of active fever illness and twenty-one courses of prednisone, is presented to the consulting ENT surgeon as the evidence base for the surgical intervention that has been deferred pending documentation of sufficient episode burden and parental readiness — cannot be disrupted by platform outage at the moment when the family's midnight episode logging is the real-time data capture that keeps the diagnostic record intact and the tonsillectomy referral timeline on track; where periodicity calculation platform availability during the immunology clinic visit for a three-year-old whose parents arrive with a handwritten fever diary showing twelve consecutive episodes over the past eleven months — when the physician must enter the episode dates into the platform, receive the automatic calculation confirming a mean interepisode interval of 27.3 days with a coefficient of variation of 0.09 that falls well within the PFAPA regularity criteria, document the corticosteroid response showing fever resolution within six hours in eleven of twelve episodes, confirm the normal growth curve and complete interictal normality, and generate the diagnostic summary letter confirming PFAPA by modified Marshall criteria with recommendation for tonsillectomy consultation — must be available for the analytical processing that transforms twelve months of parental fever documentation into the structured diagnostic output that provides the family with a clear diagnosis, explains the self-limited but recurrent nature of PFAPA, and initiates the surgical referral pathway that will resolve the condition in the majority of children within weeks of tonsillectomy; and where corticosteroid abort therapy prescribing platform availability when the family calls at 9:15 AM on a school day — their child just woke with 39.4°C fever and the two aphthous ulcers that signal episode onset while his teacher is expecting him for the spring class trip tomorrow — when the nurse must access the medication record confirming prior corticosteroid abort courses, review the interval-shortening documentation confirming no shortening effect in this patient, and send the electronic prescription for prednisone 20 mg oral single dose that will abort the fever within four to eight hours and allow the child to attend the class trip the following day — cannot be compromised at the clinical prescribing moment where platform availability is the direct determinant of whether a child receives abort therapy that resolves his fever in hours or waits five more days for spontaneous resolution while missing the spring school trip, his sister's birthday party, and two days of kindergarten. A fever diary system that fails when a family is trying to log episode onset at midnight, a periodicity calculation platform unavailable when the immunologist is generating the tonsillectomy referral package, a corticosteroid prescribing platform inaccessible when the family calls for the abort dose that will resolve the episode before tomorrow's class trip — these are not IT incidents. They are clinical disruptions in the management of the most common periodic fever syndrome of childhood, where platform reliability is inseparable from the fever documentation precision, periodicity analysis accuracy, abort therapy accessibility, and surgical referral coordination that determine whether children with PFAPA receive timely diagnosis, appropriate tonsillectomy referral, and the definitive surgical resolution that frees them and their families from the relentless three-to-eight-week cycle of fever, oral ulcers, sore throat, and swollen neck nodes that characterizes the clockwork burden of pediatric PFAPA syndrome.
Uptime monitoring gives PFAPA tech teams the detection capability to identify failures within seconds, trigger immediate clinical downtime procedures, and demonstrate to pediatric immunology programs, ENT surgical departments, general pediatrics practices, school health services, and compliance auditors that platform operational reliability matches the documentation urgency, analytical precision, abort therapy accessibility, and surgical coordination demands of modern PFAPA syndrome care.
Start monitoring your PFAPA care tech platform for free at vigilmon.online — HTTP/HTTPS monitoring, multi-region consensus alerting, SSL certificate monitoring, automatic status page, Slack and webhook alerts. No agent required. No credit card.
Tags: #monitoring #PFAPA #PeriodicFever #AphthousStomatitis #Pharyngitis #Adenitis #periodicFeverSyndrome #autoinflammatory #tonsillectomy #prednisone #cyclicNeutropenia #MEFV #FMF #TRAPS #CAPS #HIDS #MKD #Marshall #pediatricImmunology #feverDiary #HIPAA #healthtech #digitalhealth #uptime #sre